Jubilant Life Sciences shines on receiving ANDA approval for Olmesartan Medoxomil Tablets

25 Apr 2017 Evaluate

Jubilant Life Sciences is currently trading at Rs. 829.25, up by 39.05 points or 4.94% from its previous closing of Rs. 790.20 on the BSE.

The scrip opened at Rs. 808.95 and has touched a high and low of Rs. 834.90 and Rs. 792.90 respectively. So far 52446 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.10 on 12-Apr-2017 and a 52 week low of Rs. 294.20 on 24-Jun-2016.

Last one week high and low of the scrip stood at Rs. 841.25 and Rs. 765.00 respectively. The current market cap of the company is Rs. 12693.91 crore.

The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 24.42% and 21.55% respectively.

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg, and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension. This is the second approval that the company received from the USFDA during the current financial year. As on December 31, 2016, Jubilant Life Sciences had a total of 73 ANDAs for Oral Solids filed in the US, of which 49 have been approved.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

980.85 -12.75 (-1.28%)
20-Jan-2026 11:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1649.05
Dr. Reddys Lab 1173.95
Cipla 1391.00
Zydus Lifesciences 879.85
Lupin 2164.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×